Location: Home
  • search
  • go
  • Relate News
  • 9/4/2020AbbVie Teams Up with I-Mab in Cancer
  • 9/4/2020Uni-Bio Receives IND Approval for Uni-PTH Liquid Injection in China
  • 9/4/2020CStone Gets Ready to Launch Lung Cancer Drug Sugemalimab in China Befo...
  • 9/3/2020Innovent Granted Marketing Approval for SULINNO (Adalimumab Inj) in Ch...
  • 9/3/2020Alphamab's KN046 Granted Orphan Drug Designation for TET by USFDA
  • 9/3/2020Asymchem Invests in Flow Chemistry Startup Snapdragon
  • 9/3/2020China Tightens Technology Export Control Rules
  • 9/3/2020Chi-Med Initiates PII Trial of HMPL-453 for IHCC in China
  • 9/3/2020Lancet: Chinese Population to Half by 2100 with Sharp Labor Force Decl...
  • 9/3/2020Carlyle Buys Minority Stake in Shenzhen Salubris Pharma
  • 9/2/2020NHC Publishes the List of 2nd Rare Disease Treatment and Insurance Exp...
  • 9/2/2020NMPA Issues the Dispute Resolution Procedures for Drug Evaluation Deci...
  • 9/2/2020CDE Solicits Comments on the Draft Guidelines for Clinical Pharmacolog...
  • 9/2/2020As MNCs Refocus on Innovative Drugs, Feel the Pulse of China's IP Land...
  • 9/1/2020China's Pre-Revenue Biopharma Players Continue To Be Embraced By Marke...
  • 9/1/2020HJB and Ansun Enter Strategic Deal on Biologics CMC Partnership
  • 9/1/2020Antengene Cleared to Stage $200 Million IPO in Hong Kong
  • 9/1/2020Polyphor and Fosun Pharma Announce Licensing Deal for Balixafortide in...
  • 9/1/2020CStone Receives USFDA IND Clearance for Anti-PD-L1 Sugemalimab in R/R ...
  • 8/31/2020Financial-related Company News in Brief
  • 8/31/2020Four Chinese COVID-19 Vaccines Undergoing International Phase-3 Clinic...
  • 8/31/2020SMEI Reports Chinese Pharma Performance in H1
  • 8/31/2020CDE Issues the Guidance Principles on Real World Data in Support of R&...
  • 8/30/2020McKinsey Report: Managing China's Growing Oncology Burden
  • 8/30/2020PhIIC Announces the Top 100 Pharmaceutical Companies in China 2019
  • 8/28/2020Recent Official and Executive Moves
  • 8/28/2020Biogen Granted Chinese Approval of Replagal
  • 8/28/2020Bayer Submits NDA for CCF Drug Vericiguat in China
  • 8/28/2020CDE Solicits Comments on the Draft Guidelines for Multiplicity Issues ...
  • 8/28/2020CDE Solicits Comments on the Draft Guidelines for Subgroup Analysis of...
  • Page:167/719 Total number of articles:21562: [First][<<] [165] [166] [167] [168] [169] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group